Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Gregory Pepper
Performance characteristics of highly automated HSV-1 and HSV-2 IgG testing
ALG reports contract testing from Abbott, Cepheid, Novavax, Pfizer, Janssen and Hologic, research support from Gilead, outside of the described work. CJ reports consulting fees from Assembly Biosciences and GSK and research funding from GSK and Moderna. No industry support was received for the above work, which was entirely paid for by departmental funds.
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho
Special Issue Immunoassays Andrew Bryan, Gregory Pepper, Mark H. Wener, Susan L. Fink, Chihiro Morishima, Anu Chaudhary, Keith R. Jerome, Patrick C. Mathias, Alexander L. Greninger Alexander J. McAdam, Editor DOI: 10.1128/JCM.00941-20 ABSTRACT Coronavirus disease 2019 (COVID-19), the novel respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with severe morbidity and mortality.
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence Testing in Idaho
Abstract Coronavirus disease-19 (COVID19), the novel respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with severe morbidity and mortality. The rollout of diagnostic testing in the United States was slow, leading to numerous cases that were not tested for SARS-CoV-2 in February and March 2020, necessitating the use of serological testing to determine past infections.
Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories
Abstract Multiple laboratory developed tests and commercially available assays have emerged to meet diagnostic needs related to the SARS-CoV-2 pandemic. To date, there is limited comparison data for these different testing platforms.
Gregory Pepper Announces New Album, Shares Lead Single "I've Got a Bottle"
'I Know Now Why You Cry' will arrive early next year Published Dec 16, 2019 Gregory Pepper has announced plans for his next album. It's called I Know Now Why You Cry, and it will arrive on February 14 via Fake Four Inc. The southern Ontario musician has toyed with garage rock, twee folk and electro-pop in recent years, but the latest album is his most ornate to date, featuring baroque-inspired arrangements.
Limited marginal utility of deep sequencing for HIV drug resistance testing in the age of integrase inhibitors
HIV drug resistance genotyping is a critical tool in the clinical management of HIV infections. Although resistance genotyping has traditionally been conducted using Sanger sequencing, next-generation sequencing (NGS) is emerging as a powerful tool due to its ability to detect lower frequency alleles.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Gregory
Contact Gregory, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack